Saved in:
| Main Author: | wu, wenjuan |
|---|---|
| Format: | Recurso digital |
| Language: | |
| Published: |
Zenodo
2026
|
| Online Access: | https://doi.org/10.5281/zenodo.18309045 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Revisiting intraperitoneal chemotherapy for advanced high‐grade serous ovarian cancer
by: Joshua S Cheruvathur, et al.
Published: (2025)
by: Joshua S Cheruvathur, et al.
Published: (2025)
B cells critical for outcome in high grade serous ovarian carcinoma
by: Annegé Vledder, et al.
Published: (2024)
by: Annegé Vledder, et al.
Published: (2024)
Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy
by: Luka Tandaric, et al.
Published: (2026)
by: Luka Tandaric, et al.
Published: (2026)
Plasma membrane SK2 channel activity regulates migration and chemosensitivity of high‐grade serous ovarian cancer cells
by: Olivier Romito, et al.
Published: (2024)
by: Olivier Romito, et al.
Published: (2024)
Identification of potential cell surface targets in patient‐derived cultures toward photoimmunotherapy of high‐grade serous ovarian cancer
by: Sudip Timilsina, et al.
Published: (2025)
by: Sudip Timilsina, et al.
Published: (2025)
Development and validation of a computational tool to predict treatment outcomes in cells from high‐grade serous ovarian cancer patients
by: Marilisa Cortesi, et al.
Published: (2025)
by: Marilisa Cortesi, et al.
Published: (2025)
Circulating serum miRNAs predict response to platinum chemotherapy in high‐grade serous ovarian cancer
by: Kazuhiro Suzuki, et al.
Published: (2024)
by: Kazuhiro Suzuki, et al.
Published: (2024)
Spatially resolved proteomics surveys the chemo‐refractory proteins related to high‐grade serous ovarian cancer
by: Linyuan Fan, et al.
Published: (2025)
by: Linyuan Fan, et al.
Published: (2025)
High expression of SLC7A1 in high‐grade serous ovarian cancer promotes tumor progression and is involved in MAPK/ERK pathway and EMT
by: Shijing You, et al.
Published: (2024)
by: Shijing You, et al.
Published: (2024)
Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer
by: Sophia Bielesch, et al.
Published: (2026)
by: Sophia Bielesch, et al.
Published: (2026)
Trps1 predicts poor prognosis in advanced high grade serous ovarian carcinoma
by: Xiaojiang Wang, et al.
Published: (2024)
by: Xiaojiang Wang, et al.
Published: (2024)
Plasma‐activated media selectively induces apoptotic death via an orchestrated oxidative stress pathway in high‐grade serous ovarian cancer cells
by: Lorena T. Davies, et al.
Published: (2024)
by: Lorena T. Davies, et al.
Published: (2024)
CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7 ‐ H3
by: Aya Saleh, et al.
Published: (2026)
by: Aya Saleh, et al.
Published: (2026)
Single‐cell transcriptome analysis reveals tumoral microenvironment heterogenicity and hypervascularization in human carotid body tumor
by: Gaopo Cai, et al.
Published: (2024)
by: Gaopo Cai, et al.
Published: (2024)
Tailored chemotherapy: Innovative deep‐learning model customizing chemotherapy for high‐grade serous ovarian carcinoma
by: Se Ik Kim, et al.
Published: (2024)
by: Se Ik Kim, et al.
Published: (2024)
Rates of genetic consultation in high‐grade serous ovarian cancer patients in the era of PARP inhibitor therapy: A population‐based study
by: Shannon E. Brent, et al.
Published: (2024)
by: Shannon E. Brent, et al.
Published: (2024)
Gene expression profiles associated with carboplatin chemoresistance in high-grade serous ovarian cancer: insights from 2D and 3D models
by: Konondoska Grič, Vesna, et al.
Published: (2026)
by: Konondoska Grič, Vesna, et al.
Published: (2026)
Identifying therapeutic targets in low‐grade serous ovarian carcinomas with no specific molecular profile
by: Kathleen I Pishas, et al.
Published: (2026)
by: Kathleen I Pishas, et al.
Published: (2026)
Single‐cell transcriptome analysis reveals heterogeneity of neutrophils in non‐small cell lung cancer
by: Yunzhen Wang, et al.
Published: (2024)
by: Yunzhen Wang, et al.
Published: (2024)
Detecting TP53 mutations in paired liquid and tissue biopsies from patients with high‐grade serous ovarian carcinoma
by: Amanda Olsson Widjaja, et al.
Published: (2025)
by: Amanda Olsson Widjaja, et al.
Published: (2025)
Economic impact of olaparib on maintenance treatment of patients with BRCA-mutation positive, platinum-sensitive relapsing high-grade serous epithelial ovarian cancer in Spain
by: Laura Delgado-Ortega
Published: (2018)
by: Laura Delgado-Ortega
Published: (2018)
Molecular and immunohistochemical characterization of ERBB2 activating mutations in low‐grade serous ovarian carcinoma
by: Alexander J Neil, et al.
Published: (2025)
by: Alexander J Neil, et al.
Published: (2025)
Hypoxia‐mediated high expression of TRIM15 promotes malignant progression of high‐grade serous ovarian cancer through activation of AKT signaling pathway by K63 ubiquitination
by: Wei Wei, et al.
Published: (2025)
by: Wei Wei, et al.
Published: (2025)
Single‐cell transcriptomic analysis reveals that the APP–CD74 axis promotes immunosuppression and progression of testicular tumors
by: Guo Chen, et al.
Published: (2024)
by: Guo Chen, et al.
Published: (2024)
A case of BRAF mutation‐positive recurrent ovarian high‐grade serous carcinoma with remarkable response to combined dabrafenib and trametinib therapy
by: Tatsuhito Furui, et al.
Published: (2025)
by: Tatsuhito Furui, et al.
Published: (2025)
Single‐cell transcriptomic analysis reveals a metastasis‐associated PCSK1 + neuroendocrine subpopulation in pancreatic neuroendocrine tumors
by: Xiaolei Yin, et al.
Published: (2025)
by: Xiaolei Yin, et al.
Published: (2025)
Comparative prognosis analysis of ovarian squamous cell carcinoma versus serous carcinoma: Insights from the SEER database
by: Xianglin Nie, et al.
Published: (2024)
by: Xianglin Nie, et al.
Published: (2024)
Single‐cell transcriptomics reveals IRF7 regulation of the tumor microenvironment in isocitrate dehydrogenase wild‐type glioma
by: Jinwei Li, et al.
Published: (2024)
by: Jinwei Li, et al.
Published: (2024)
Insights into the heterogeneity of the tumor microenvironment in lung adenocarcinoma and squamous carcinoma through single‐cell transcriptomic analysis: Implications for distinct immunotherapy outcomes
by: Xinyun Fang, et al.
Published: (2024)
by: Xinyun Fang, et al.
Published: (2024)
CRISPR/Cas9‐edited tumor‐associated immune cells in cancer immunotherapy
by: Yuhui Ma, et al.
Published: (2025)
by: Yuhui Ma, et al.
Published: (2025)
Single‐cell transcriptome sequencing reveals SPP1‐CD44‐mediated macrophage–tumor cell interactions drive chemoresistance in TNBC
by: Fuzhong Liu, et al.
Published: (2024)
by: Fuzhong Liu, et al.
Published: (2024)
Single‐cell transcriptomics reveals antigen‐presenting capacity and therapeutic resistance potential of immunomodulatory endothelial cells in colorectal cancer
by: Jingyi Wen
Published: (2024)
by: Jingyi Wen
Published: (2024)
Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer
by: Laura Glossner, et al.
Published: (2025)
by: Laura Glossner, et al.
Published: (2025)
Targeting polymorphonuclear myeloid‐derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy
by: Shiqi Li, et al.
Published: (2024)
by: Shiqi Li, et al.
Published: (2024)
The potential value of cancer‐testis antigens in ovarian cancer: Prognostic markers and targets for immunotherapy
by: Lina Lin, et al.
Published: (2024)
by: Lina Lin, et al.
Published: (2024)
Single‐cell transcriptomic analysis of B cells reveals new insights into atypical memory B cells in COVID‐19
by: Melissa García‐Vega, et al.
Published: (2024)
by: Melissa García‐Vega, et al.
Published: (2024)
Single‐cell transcriptomic analysis reveals APOE genotype‐dependent sex differences in Alzheimer's disease
by: Gefei Yu, et al.
Published: (2026)
by: Gefei Yu, et al.
Published: (2026)
Single‐cell transcriptome analysis reveals keratinocyte subpopulations contributing to psoriasis in corneum and granular layer
by: Qianya Zhao, et al.
Published: (2024)
by: Qianya Zhao, et al.
Published: (2024)
Deciphering head and neck cancer microenvironment: Single‐cell and spatial transcriptomics reveals human papillomavirus‐associated differences
by: Hansong Lee, et al.
Published: (2024)
by: Hansong Lee, et al.
Published: (2024)
Single‐cell transcriptomic landscape reveals distinct tumourigenesis and immune microenvironments in secondary radiation‐exposed rectal cancer
by: Xu Guan, et al.
Published: (2024)
by: Xu Guan, et al.
Published: (2024)
Similar Items
-
Revisiting intraperitoneal chemotherapy for advanced high‐grade serous ovarian cancer
by: Joshua S Cheruvathur, et al.
Published: (2025) -
B cells critical for outcome in high grade serous ovarian carcinoma
by: Annegé Vledder, et al.
Published: (2024) -
Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy
by: Luka Tandaric, et al.
Published: (2026) -
Plasma membrane SK2 channel activity regulates migration and chemosensitivity of high‐grade serous ovarian cancer cells
by: Olivier Romito, et al.
Published: (2024) -
Identification of potential cell surface targets in patient‐derived cultures toward photoimmunotherapy of high‐grade serous ovarian cancer
by: Sudip Timilsina, et al.
Published: (2025)